Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51,692 | 36,053 | 25,574 | 32,786 | 45,414 |
| Marketable Securities | 9,422 | 13,049 | 23,976 | 24,147 | 16,937 |
| Receivables | 30,575 | 28,904 | 27,512 | 30,550 | 23,546 |
| Inventories | 4,784 | 8,059 | 6,579 | 5,522 | 6,112 |
| TOTAL | $106,467 | $94,723 | $92,486 | $99,266 | $95,024 |
| Non-Current Assets | |||||
| PPE Net | 99 | 115 | 140 | 165 | 190 |
| Intangibles | 27,687 | 28,275 | 28,863 | 13,878 | 14,146 |
| Other Non-Current Assets | 5,166 | 5,295 | 5,030 | 3,916 | 5,964 |
| TOTAL | $32,952 | $33,685 | $34,033 | $17,959 | $20,300 |
| Total Assets | $139,419 | $128,408 | $126,519 | $117,225 | $115,324 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,815 | 6,130 | 9,276 | 7,142 | 7,999 |
| Accrued Expenses | 11,517 | 11,045 | 9,373 | 12,189 | 13,847 |
| Other current liabilities | 27,192 | 33,547 | 32,270 | 19,326 | 19,369 |
| TOTAL | $54,312 | $58,649 | $73,198 | $53,267 | $48,273 |
| Non-Current Liabilities | |||||
| Long Term Debt | 59,762 | 59,692 | 44,910 | 52,373 | 59,659 |
| Deferred Revenues | 1,355 | 1,355 | 1,355 | 1,355 | 1,355 |
| Other Non-Current Liabilities | 39,981 | 39,981 | 39,982 | 40,229 | 39,226 |
| TOTAL | $99,743 | $99,673 | $84,992 | $92,602 | $98,885 |
| Total Liabilities | $154,055 | $158,322 | $158,190 | $145,869 | $147,158 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,615 | 17,595 | 17,541 | 17,538 | 17,437 |
| Common Shares | 17 | 17 | 175 | 17 | 175 |
| Retained earnings | -1,404,406 | -1,416,827 | -1,415,797 | -1,407,550 | -1,408,287 |
| Other shareholders' equity | 11 | -9 | -5 | 8 | -15 |
| TOTAL | $-14,636 | $-29,914 | $-31,671 | $-28,644 | $-31,834 |
| Total Liabilities And Equity | $139,419 | $128,408 | $126,519 | $117,225 | $115,324 |